Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil Liposomes in Atherosclerotic Occlusive Disease
NCT02877173Phase 2Unknown
- Sponsor
- ApicHope Pharmaceutical Group
- Start
- Aug 2016
- Primary completion
- Jul 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of alprostadil liposomal in arteriosclerosis obliterans, sponsored by ApicHope Pharmaceutical Group. Status: unknown.
02
Drugs
alprostadil liposomal
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on NCT02877173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02877173.